Shining a light on middlemen who are making prescriptions more expensive is one important step to bolster competition.
Editor's note · Context
Guthrie advocates for transparency regarding middlemen in the prescription drug market.
Share
More from Brett Guthrie
We’re not competing with Europe to regulate. We’re competing with China to regulate.
All I will say is that we know, and we have had testimony. We have had testimony from so many people who have come before our committee. We know that if we have illicit fentanyl that is no longer illegal, it is not going to save lives. It…
We are going to work on the SUPPORT Act, but the vote before us today that people are going to put their names to, a yes or no: Do we want to make illegal derivatives of fentanyl produced and conceived in China sent to Mexico and across…
You are subsidizing one side of it, not the other, and quite honestly, putting in roadblocks for what is the most important thing--is generating power.





